arBtrage CAPITALIZING MARKETS checking… Sign in

WAVE Life Sciences Ltd.

WVE Health Care Biotechnology: Pharmaceutical Preparations
$5.73
▼ -5.9% Today
as of Jun 7, 07:32 ET
Last 30 days -23.80% Apr 28 → Jun 05
$5.54 $6.07 $6.61 $7.14 $7.67 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$6.08
High
$6.12
Low
$5.61
Volume
$4M
Avg Vol
$4M
Mkt Cap
$1.2B
P/E (TTM)
Beta
52w High
$21.73
52w Low
$5.02
Div Yield
Shares Out
$192M

Overview

52-week range
$5.02
$22
4% of range
Avg surprise (last 1)
-7.4%
Avg reaction (last 1)
+0.8%
100% positive
Latest IV / EM
110%
EM ±15.3% · $6 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.47$-0.33$-0.20$-0.06$0.07 Actual $-0.20Actual $0.07Actual $-0.24Actual $-0.25Actual $-0.47Actual $-0.29Est $-0.27Actual $-0.31Actual $-0.32Actual $-0.13 JunSepMarJunSepMar/2025JunSepMar
Revenue vs Net Income Revenue Net income
$-62M$-53M$-45M$-36M$-27M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Mar 31, 2026Mar 2026 $-0.13 financials
Tue Sep 30, 2025Sep 2025 $-0.32 financials
Mon Jun 30, 2025Jun 2025 $-0.31 financials
Thu May 8, 2025Mar/2025 $-0.29 $-0.27 -7.4% +0.8% earnings
Mon Sep 30, 2024Sep 2024 $-0.47 financials
Sun Jun 30, 2024Jun 2024 $-0.25 financials
Sun Mar 31, 2024Mar 2024 $-0.24 financials
Sat Sep 30, 2023Sep 2023 $0.07 financials
Fri Jun 30, 2023Jun 2023 $-0.20 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-31M$-56M$-53M$-50M$-64M$-35M
Net income$-26M$-54M$-50M$-47M$-62M$-33M
EPS (diluted)$-0.13$-0.32$-0.31$-0.29$-0.47$-0.25

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$545M$602M$196M$208M$243M$302M$311M$154M
Inventory
Total current assets$561M$615M$215M$224M$258M$320M$325M$172M
Total assets$584M$638M$241M$252M$288M$352M$359M$209M
Long-term debt
Total liabilities$72M$112M$109M$105M$109M$135M$209M$204M
Total equity$512M$518M$125M$139M$172M$210M$142M$-3M

Implied volatility — last 90 days

105%107%110%112%115% Jun 07 — IV 110% · EM ±15.3%

Sector peers